Noriko Koizumi

Direttore/Membro del Consiglio presso SEED CO.,LTD.

54 anni

Consumer Services

Health Technology

Technology Services

Profilo

Noriko Koizumi is an Independent Outside Director at Seed Co., Ltd., a Professor at Doshisha University, the Chief Scientific Officer at ActualEyes, Inc., and a Professor at Graduate School of Medicine Kyoto University.
She received her undergraduate and doctorate degrees from Kyoto Prefectural University of Medicine.

Posizioni attive di Noriko Koizumi

Società	Posizione	Inizio
SEED CO.,LTD.	Direttore/Membro del Consiglio	24/06/2022
Doshisha University	Corporate Officer/Principal	01/04/2010
Graduate School of Medicine Kyoto University	Corporate Officer/Principal	01/04/2015
ActualEyes, Inc. ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka.	Direttore Tecnico/Scientifico/R&S	01/05/2018

Tutte le posizioni attive di Noriko Koizumi

Formazione di Noriko Koizumi

Kyoto Prefectural University of Medicine

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Noriko Koizumi

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
SEED CO.,LTD.	Health Technology

Aziende private	1
ActualEyes, Inc. ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka.	Technology Services